Source:http://linkedlifedata.com/resource/pubmed/id/18800063
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-2-10
|
pubmed:abstractText |
This study investigated how the administration (acute and chronic) of the antidepressants citalopram and desmethylimipramine (DMI) influences somatostatin (somatotropin release inhibitory factor, SRIF) levels and SRIF receptor density (sst(1-5)) in rat brain. Animals received either of the following treatments: (1) saline for 21 days (control group), (2) saline for 20 days and citalopram or DMI for 1 day (citalopram or DMI acute groups), (3) citalopram or DMI for 21 days (citalopram or DMI chronic groups). Somatostatin levels were determined by radioimmunoassay. [(125)I]LTT SRIF-28 binding in the absence (labeling of sst(1-5)) or presence of 3 nM MK678 (labeling of sst(1/4)) and [(125)I]Tyr(3) octreotide (labeling of sst(2/5)) binding with subsequent autoradiography was performed in brains of rats treated with both antidepressants. Somatostatin levels were increased after citalopram, but not DMI administration, in the caudate-putamen, hippocampus, nucleus accumbens, and prefrontal cortex. Autoradiography studies illustrated a significant decrease in receptor density in the superficial and deep layers of frontal cortex (sst(2)), as well as a significant increase in the CA1 (sst(1/4)) hippocampal field in brains of chronically citalopram-treated animals. DMI administration increased sst(1/4) receptors levels in the CA1 hippocampal region. These results suggest that citalopram and to a lesser extent DMI influence the function of the somatostatin system in brain regions involved in the emotional, motivational, and cognitive aspects of behavior.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Citalopram,
http://linkedlifedata.com/resource/pubmed/chemical/Desipramine,
http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Octreotide,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Somatostatin,
http://linkedlifedata.com/resource/pubmed/chemical/Somatostatin,
http://linkedlifedata.com/resource/pubmed/chemical/seglitide
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1740-634X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
952-63
|
pubmed:dateRevised |
2011-5-18
|
pubmed:meshHeading |
pubmed-meshheading:18800063-Analysis of Variance,
pubmed-meshheading:18800063-Animals,
pubmed-meshheading:18800063-Antidepressive Agents,
pubmed-meshheading:18800063-Autoradiography,
pubmed-meshheading:18800063-Brain,
pubmed-meshheading:18800063-Citalopram,
pubmed-meshheading:18800063-Desipramine,
pubmed-meshheading:18800063-Immunoassay,
pubmed-meshheading:18800063-Iodine Radioisotopes,
pubmed-meshheading:18800063-Male,
pubmed-meshheading:18800063-Octreotide,
pubmed-meshheading:18800063-Peptides, Cyclic,
pubmed-meshheading:18800063-Rats,
pubmed-meshheading:18800063-Rats, Sprague-Dawley,
pubmed-meshheading:18800063-Receptors, Somatostatin,
pubmed-meshheading:18800063-Somatostatin
|
pubmed:year |
2009
|
pubmed:articleTitle |
Antidepressants influence somatostatin levels and receptor pharmacology in brain.
|
pubmed:affiliation |
Department of Basic Sciences, Laboratory of Pharmacology, Faculty of Medicine, University of Crete, Heraklion, Crete, Greece.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|